Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Mani Mohindru

CEO at Cardiff Oncology, Inc. (CRDF)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+5.4%
vs. S&P 500+1.2%
Beat the market100%
Paper profit on buys−$16K
Total bought / sold$80K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Jul 16SEC CRDFCardiff Oncology, Inc. Buy 34,36459,067 held (+139%) $1.46 $50K -26.0%
Jun 22SEC CRDFCardiff Oncology, Inc. Buy 24,703new position $1.21 $30K -10.7%
  • Buy

    CEO Mani Mohindru bought $50K of CRDF at $1.46 — largest purchase by this insider in our records; raises the stake by 139%.

  • Buy

    CEO Mani Mohindru bought $30K of CRDF at $1.21 — first open-market purchase in our records; opens a new position.